Edwards Lifesciences Corp. Annual Results: Standalone & Consolidated Reports

Annual Results

Results Snapshot

Figures in Million

Consolidate Annual Results

Dec'24

Dec'23

Dec'22

Dec'21

Dec'20

Dec'19

Dec'18

Net Sales

5,439.50

5,010.00

5,382.40

5,232.50

4,386.30

4,348.00

3,722.80

Other Operating Income

0.00

Total Operating income

5,439.50

5,010.00

5,382.40

5,232.50

4,386.30

4,348.00

3,722.80

Raw Material Cost

1,153.30

1,037.30

1,167.20

1,225.90

1,099.00

1,155.30

922.10

Purchase of Finished goods

0.00

(Increase) / Decrease In Stocks

0.00

Employee Cost

0.00

Power Cost

0.00

Manufacturing Expenses

19.80

17.60

26.20

24.80

22.20

27.30

33.40

Selling and Distribution Expenses

1,789.20

1,582.50

1,567.60

1,493.10

1,230.60

1,242.10

1,086.20

Other Expenses

103.32

94.53

91.90

87.83

73.85

72.54

58.88

Total Expenditure (Excl Depreciation)

3,995.50

3,582.70

3,680.00

3,622.10

3,090.30

3,150.10

2,630.50

Operating Profit (PBDIT) excl Other Income

1444

1427.3

1702.4

1610.3999999999999

1296

1197.9

1092.3

Other Income

165.20

126.10

89.60

-14.50

78.40

88.10

16.20

Operating Profit (PBDIT)

1,764.70

1,698.30

1,958.80

1,759.20

1,509.80

1,400.60

1,185.90

Interest

19.80

17.60

26.20

24.80

22.20

27.30

33.40

Exceptional Items

-41.60

-163.40

1.60

130.90

-435.50

-92.20

-313.70

Gross Profit (PBDT)

4,286.20

3,972.70

4,215.20

4,006.60

3,287.30

3,192.70

2,800.70

Depreciation

155.20

144.90

166.80

163.30

135.40

114.60

77.40

Profit Before Tax

1,548.10

1,372.40

1,767.40

1,702.00

916.70

1,166.50

761.40

Tax

152.10

152.40

245.50

198.90

93.30

119.60

39.20

Provisions and contingencies

0.00

Profit After Tax

1,400.90

1,223.00

1,521.90

1,503.10

823.40

1,046.90

722.20

Extraordinary Items

0.00

Prior Period Expenses

0.00

Other Adjustments

0.00

Net Profit

1,400.90

1,223.00

1,521.90

1,503.10

823.40

1,046.90

722.20

Share in Profit of Associates

0.00

Minority Interest

-4.90

-3.00

0.00

Other related items

0.00

Consolidated Net Profit

1,396.00

1,220.00

1,521.90

1,503.10

823.40

1,046.90

722.20

Equity Capital

0.00

Face Value

1.0

Reserves

9,998.40

6,650.00

5,806.70

5,835.90

4,574.30

4,148.30

3,140.40

Earnings per share (EPS)

1.46

2.3

2.44

2.38

1.3

1.64

1.13

Diluted Earnings per share

1.46

2.3

2.44

2.38

1.3

1.64

1.13

Operating Profit Margin (Excl OI)

26.55%

28.49%

31.63%

30.78%

29.55%

27.55%

29.34%

Gross Profit Margin

31.31%

30.29%

35.94%

35.65%

23.99%

29.46%

22.53%

PAT Margin

25.75%

24.41%

28.28%

28.73%

18.77%

24.08%

19.4%

Public Share Holdings (%)

0.0%

Pledged Promotor Holding (%)

0.0%

Annual Analysis Highlights

Net Sales

YoY Growth in year ended Dec 2024 is 8.57% vs -6.92% in Dec 2023

Consolidate Net Profit

YoY Growth in year ended Dec 2024 is 14.43% vs -19.84% in Dec 2023

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2024 is 1.74% vs -15.89% in Dec 2023

Interest

YoY Growth in year ended Dec 2024 is 12.50% vs -32.82% in Dec 2023

Operating Profit Margin (Excl OI)

YoY Growth in year ended Dec 2024 has fallen from Dec 2023

Compare Annual Results Of Edwards Lifesciences Corp. With

Select Peers

Figures in Million

Consolidate Annual Results

Change(USD)

Change(%)

Net Sales

5,439.50

20,178.00

-14,738.50

-73.04%

Other Operating Income

0.00

Total Operating income

5,439.50

20,178.00

-14,738.50

-73.04%

Raw Material Cost

1,153.30

11,053.00

-9,899.70

-89.57%

Purchase of Finished goods

0.00

(Increase) / Decrease In Stocks

0.00

Employee Cost

0.00

Power Cost

0.00

Manufacturing Expenses

19.80

528.00

-508.20

-96.25%

Selling and Distribution Expenses

1,789.20

4,857.00

-3,067.80

-63.16%

Other Expenses

103.32

66.20

37.12

56.07%

Total Expenditure (Excl Depreciation)

3,995.50

17,100.00

-13,104.50

-76.63%

Operating Profit (PBDIT) excl Other Income

1,444.00

3,078.00

-1,634.00

-53.09%

Other Income

165.20

122.00

43.20

35.41%

Operating Profit (PBDIT)

1,764.70

5,353.00

-3,588.30

-67.03%

Interest

19.80

528.00

-508.20

-96.25%

Exceptional Items

-41.60

-676.00

634.40

93.85%

Gross Profit (PBDT)

4,286.20

9,125.00

-4,838.80

-53.03%

Depreciation

155.20

2,144.00

-1,988.80

-92.76%

Profit Before Tax

1,548.10

2,005.00

-456.90

-22.79%

Tax

152.10

300.00

-147.90

-49.30%

Provisions and contingencies

0.00

Profit After Tax

1,400.90

1,705.00

-304.10

-17.84%

Extraordinary Items

0.00

Prior Period Expenses

0.00

Other Adjustments

0.00

Net Profit

1,400.90

1,705.00

-304.10

-17.84%

Share in Profit of Associates

0.00

Minority Interest

-4.90

0.00

-4.90

Other related items

0.00

Consolidated Net Profit

1,396.00

1,705.00

-309.00

-18.12%

Equity Capital

0.00

Face Value

1.00

0.00

Reserves

9,998.40

25,890.00

-15,891.60

-61.38%

Earnings per share (EPS)

1.46

5.86

-4.40

-75.09%

Diluted Earnings per share

1.46

5.86

-4.40

-75.09%

Operating Profit Margin (Excl OI)

26.55%

15.30%

0.00

11.25%

Gross Profit Margin

31.31%

20.56%

0.00

10.75%

PAT Margin

25.75%

8.45%

0.00

17.30%

Public Share Holdings (%)

0.00

0.00%

Pledged Promotor Holding (%)

0.00

0.00%

Annual - Net Sales

Net Sales 543.95 Million

in Dec 2024

Figures in Million

YoY Growth in year ended Dec 2024 is 8.57% vs -6.92% in Dec 2023

Annual - Consolidate Net Profit

Consolidate Net Profit 139.60 Million

in Dec 2024

Figures in Million

YoY Growth in year ended Dec 2024 is 14.43% vs -19.84% in Dec 2023

Annual - Operating Profit (PBDIT)

Operating Profit (PBDIT) 159.95 Million

in Dec 2024

Figures in Million

YoY Growth in year ended Dec 2024 is 1.74% vs -15.89% in Dec 2023

Annual - Interest

Interest 1.98 Million

in Dec 2024

Figures in Million

YoY Growth in year ended Dec 2024 is 12.50% vs -32.82% in Dec 2023

Annual - Operating Profit Margin (Excl OI)

Operating Profit Margin (Excl OI) 26.55%

in Dec 2024

Figures in %

YoY Growth in year ended Dec 2024 has fallen from Dec 2023